Skip to content
healthcare.dev

Bortezomib

NDC 68001-541, Bortezomib, injection, powder, lyophilized, for solution, from BluePoint Laboratories.

Product NDC
68001-541
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209622
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-541 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB3.5 mg/3.5mL

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
68001-541-36680010541361 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) / 3.5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c6b620c6-f3d6-4ff3-b46a-50a66e6d41dd
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68001-541

Use it

Look up 68001-541 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-541 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-541. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.